# Max Biotech Diabetes (Max Biotech Diabetes Limited)

Private limited company registered in Birmingham, classed under “Research and experimental development on biotechnology”.

- Company number: 15705021
- Status: Active
- Type: Private limited company
- Incorporated: 7 May 2024
- Registered office: 20 Farquhar Road, Edgbaston, Birmingham, B15 3RB
- Location: Birmingham
- Activity: Research and experimental development on biotechnology

## Latest filed profit

No profit figure in its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Max Biotech Diabetes do?

Private limited company registered in Birmingham, classed under “Research and experimental development on biotechnology”.

### How much turnover does Max Biotech Diabetes make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/max-biotech-diabetes-15705021

### Is Max Biotech Diabetes profitable?

Max Biotech Diabetes's profit isn't public: small companies may file without a profit and loss account.

### How many people work at Max Biotech Diabetes?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/max-biotech-diabetes-15705021

### Who runs and owns Max Biotech Diabetes?

Its directors are Sunil Shah. Its owners are shown to subscribers.

### Where is Max Biotech Diabetes based?

Its registered office is 20 Farquhar Road, Edgbaston, Birmingham, B15 3RB, in Birmingham.

### When was Max Biotech Diabetes founded?

Max Biotech Diabetes Limited was incorporated on 7 May 2024.

### Is Max Biotech Diabetes still trading?

The register lists Max Biotech Diabetes Limited as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-06-02: Compulsory strike-off action has been discontinued
- 2026-05-31: Change of details for Ss Invest (Uk) Limited as a person with significant control on 6 May 2025 (and 2 more like it since 29 May 2026)
- 2026-05-31: Accounts for a dormant company made up to 31 May 2025
- 2026-05-29: Cessation of Sean Ngu as a person with significant control on 6 May 2025
- 2026-05-29: Cessation of Kate Cheang as a person with significant control on 6 May 2025
- 2026-05-29: Termination of appointment of Sean Ngu as a director on 6 May 2025
- 2026-04-07: First Gazette notice for compulsory strike-off
- 2024-05-07: Incorporation

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/max-biotech-diabetes-15705021